A detailed history of Sequoia Financial Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Sequoia Financial Advisors, LLC holds 68,449 shares of ABBV stock, worth $12 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
68,449
Previous 55,401 23.55%
Holding current value
$12 Million
Previous $9.5 Million 42.25%
% of portfolio
0.15%
Previous 0.12%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$163.84 - $199.33 $2.14 Million - $2.6 Million
13,048 Added 23.55%
68,449 $13.5 Million
Q2 2024

Jul 15, 2024

BUY
$154.79 - $180.76 $184,045 - $214,923
1,189 Added 2.19%
55,401 $9.5 Million
Q1 2024

Apr 30, 2024

SELL
$159.82 - $182.1 $1.74 Million - $1.98 Million
-10,873 Reduced 16.71%
54,212 $9.87 Million
Q4 2023

Jan 25, 2024

BUY
$137.6 - $154.97 $3.57 Million - $4.02 Million
25,923 Added 66.19%
65,085 $10.1 Million
Q3 2023

Nov 08, 2023

BUY
$133.59 - $154.65 $213,610 - $247,285
1,599 Added 4.26%
39,162 $5.84 Million
Q2 2023

Aug 08, 2023

BUY
$132.51 - $164.9 $18,153 - $22,591
137 Added 0.37%
37,563 $5.06 Million
Q1 2023

Apr 24, 2023

BUY
$144.61 - $166.54 $119,303 - $137,395
825 Added 2.25%
37,426 $5.96 Million
Q4 2022

Feb 10, 2023

SELL
$138.31 - $165.87 $88,656 - $106,322
-641 Reduced 1.72%
36,601 $5.92 Million
Q4 2022

Jan 17, 2023

SELL
$138.31 - $165.87 $903,302 - $1.08 Million
-6,531 Reduced 14.92%
37,242 $0
Q3 2022

Oct 26, 2022

SELL
$134.21 - $153.93 $378,606 - $434,236
-2,821 Reduced 6.05%
43,773 $5.88 Million
Q2 2022

Jul 22, 2022

SELL
$137.62 - $174.96 $1.15 Million - $1.46 Million
-8,362 Reduced 15.22%
46,594 $7.14 Million
Q1 2022

May 13, 2022

SELL
$131.98 - $163.75 $2.54 Million - $3.15 Million
-19,235 Reduced 25.93%
54,956 $8.91 Million
Q4 2021

Feb 11, 2022

BUY
$107.43 - $135.93 $6.42 Million - $8.12 Million
59,716 Added 412.55%
74,191 $10 Million
Q3 2021

Oct 26, 2021

SELL
$106.4 - $120.78 $4.48 Million - $5.09 Million
-42,152 Reduced 74.44%
14,475 $1.56 Million
Q2 2021

Jul 27, 2021

BUY
$105.21 - $117.21 $1.14 Million - $1.27 Million
10,848 Added 23.7%
56,627 $6.38 Million
Q1 2021

May 14, 2021

BUY
$102.3 - $112.62 $146,289 - $161,046
1,430 Added 3.22%
45,779 $4.95 Million
Q4 2020

Feb 12, 2021

BUY
$80.49 - $108.67 $315,279 - $425,660
3,917 Added 9.69%
44,349 $4.75 Million
Q3 2020

Oct 23, 2020

BUY
$85.91 - $100.83 $159,019 - $186,636
1,851 Added 4.8%
40,432 $3.54 Million
Q2 2020

Aug 11, 2020

BUY
$73.37 - $98.18 $285,702 - $382,312
3,894 Added 11.23%
38,581 $3.79 Million
Q1 2020

May 11, 2020

BUY
$64.5 - $97.79 $527,352 - $799,531
8,176 Added 30.84%
34,687 $2.64 Million
Q4 2019

Feb 13, 2020

BUY
$72.13 - $90.25 $1.02 Million - $1.28 Million
14,169 Added 114.8%
26,511 $2.35 Million
Q3 2019

Oct 22, 2019

BUY
$62.98 - $75.72 $126,526 - $152,121
2,009 Added 19.44%
12,342 $935,000
Q2 2019

Jul 31, 2019

BUY
$65.7 - $83.98 $60,312 - $77,093
918 Added 9.75%
10,333 $751,000
Q1 2019

May 13, 2019

BUY
$77.14 - $90.79 $87,553 - $103,046
1,135 Added 13.71%
9,415 $759,000
Q4 2018

Feb 14, 2019

BUY
$77.85 - $96.01 $85,790 - $105,803
1,102 Added 15.35%
8,280 $763,000
Q3 2018

Nov 14, 2018

SELL
$88.91 - $98.84 $27,295 - $30,343
-307 Reduced 4.1%
7,178 $679,000
Q2 2018

Aug 14, 2018

BUY
$89.78 - $106.23 $22,445 - $26,557
250 Added 3.46%
7,485 $694,000
Q1 2018

May 14, 2018

BUY
$92.01 - $123.21 $207,206 - $277,468
2,252 Added 45.19%
7,235 $685,000
Q4 2017

Feb 13, 2018

BUY
$89.56 - $98.21 $5,463 - $5,990
61 Added 1.24%
4,983 $482,000
Q3 2017

Nov 13, 2017

BUY
$69.85 - $89.22 $2,305 - $2,944
33 Added 0.67%
4,922 $437,000
Q2 2017

Aug 09, 2017

BUY
N/A
4,889
4,889 $355,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $309B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Sequoia Financial Advisors, LLC Portfolio

Follow Sequoia Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sequoia Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sequoia Financial Advisors, LLC with notifications on news.